Drug Detail:Roszet (Ezetimibe and rosuvastatin)
Generic Name: ROSUVASTATIN CALCIUM 5.2mg, EZETIMIBE 10mg
Dosage Form: tablet
Drug Class: Antihyperlipidemic combinations
Drug Detail:Roszet (Ezetimibe and rosuvastatin)
Generic Name: ROSUVASTATIN CALCIUM 5.2mg, EZETIMIBE 10mg
Dosage Form: tablet
Drug Class: Antihyperlipidemic combinations
Initiate ROSZET at 5 mg/10 mg daily due to increased rosuvastatin plasma concentrations. Consider the risk/benefit when treating Asian patients not adequately controlled at doses up to 20 mg/10 mg once daily [see Warnings and Precautions (5.1), Use in Specific Populations (8.8), and Clinical Pharmacology (12.3)].
In patients with severe renal impairment (CLcr less than 30 mL/min/1.73 m2) not on hemodialysis, the recommended starting dosage is 5 mg/10 mg once daily and should not exceed 10 mg/10 mg once daily [see Warnings and Precautions (5.1) and Use in Specific Populations (8.6)].
There are no dosage adjustment recommendations for patients with mild and moderate renal impairment.
Darolutamide
Do not exceed ROSZET 5 mg/10 mg once daily.
Regorafenib
Do not exceed ROSZET 10 mg/10 mg once daily.
Antiviral Medications
Concomitant use of sofosbuvir/velpatasvir/voxilaprevir and ledipasvir/sofosbuvir with ROSZET is not recommended.
In patients taking simeprevir, dasabuvir/ombitasvir/paritaprevir/ritonavir, elbasvir/grazoprevir, sofosbuvir/velpatasvir, glecaprevir/pibrentasvir, atazanavir/ritonavir, and lopinavir/ritonavir initiate ROSZET at 5 mg/10 mg once daily. Do not exceed ROSZET 10 mg/10 mg once daily.
No dose adjustment is needed for concomitant use with fosamprenavir/ritonavir or tipranavir/ritonavir.